Wilkins Investment Counsel Inc. Has $4.96 Million Position in Colgate-Palmolive (CL)
Wilkins Investment Counsel Inc. decreased its position in shares of Colgate-Palmolive (NYSE:CL) by 4.0% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 68,050 shares of the company’s stock after selling 2,800 shares during the period. Colgate-Palmolive accounts for 1.5% of Wilkins Investment Counsel Inc.’s investment portfolio, making the stock its 28th biggest holding. Wilkins Investment Counsel Inc.’s holdings in Colgate-Palmolive were worth $4,957,000 at the end of the most recent reporting period.
Other institutional investors have also recently added to or reduced their stakes in the company. Jacobi Capital Management LLC lifted its position in Colgate-Palmolive by 125.5% during the 3rd quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock worth $104,000 after acquiring an additional 803 shares during the last quarter. Krilogy Financial LLC lifted its position in Colgate-Palmolive by 23.0% during the 2nd quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock worth $115,000 after acquiring an additional 289 shares during the last quarter. Hanson & Doremus Investment Management lifted its position in Colgate-Palmolive by 4.5% during the 2nd quarter. Hanson & Doremus Investment Management now owns 1,630 shares of the company’s stock worth $121,000 after acquiring an additional 70 shares during the last quarter. Captrust Financial Advisors acquired a new position in Colgate-Palmolive during the 2nd quarter worth $122,000. Finally, AlphaMark Advisors LLC lifted its position in Colgate-Palmolive by 1.5% during the 2nd quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock worth $126,000 after acquiring an additional 25 shares during the last quarter. 72.83% of the stock is owned by hedge funds and other institutional investors.
Shares of Colgate-Palmolive (CL) opened at $74.62 on Friday. The firm has a market cap of $65,462.75, a PE ratio of 28.81, a P/E/G ratio of 3.15 and a beta of 0.80. Colgate-Palmolive has a 52 week low of $63.43 and a 52 week high of $77.27. The company has a debt-to-equity ratio of 24.42, a current ratio of 1.23 and a quick ratio of 0.92.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, February 15th. Investors of record on Tuesday, January 23rd will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 2.14%. Colgate-Palmolive’s payout ratio is currently 61.78%.
CL has been the subject of a number of research analyst reports. Zacks Investment Research lowered shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Wednesday, September 20th. Morgan Stanley raised shares of Colgate-Palmolive from an “equal weight” rating to an “overweight” rating and upped their price objective for the company from $75.00 to $84.00 in a research report on Monday, September 25th. Jefferies Group reaffirmed a “hold” rating and set a $79.00 price objective on shares of Colgate-Palmolive in a research report on Thursday, September 28th. Royal Bank of Canada reaffirmed a “hold” rating and set a $74.00 price objective on shares of Colgate-Palmolive in a research report on Sunday, October 8th. Finally, SunTrust Banks raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and upped their price objective for the company from $65.00 to $85.00 in a research report on Wednesday, October 11th. Two investment analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and six have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $76.51.
In related news, insider Victoria L. Dolan sold 10,000 shares of the company’s stock in a transaction dated Thursday, November 9th. The shares were sold at an average price of $73.07, for a total value of $730,700.00. Following the sale, the insider now owns 60,528 shares of the company’s stock, valued at $4,422,780.96. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Jennifer Daniels sold 902 shares of the company’s stock in a transaction dated Tuesday, January 9th. The stock was sold at an average price of $75.82, for a total transaction of $68,389.64. Following the sale, the insider now directly owns 37,788 shares in the company, valued at $2,865,086.16. The disclosure for this sale can be found here. In the last three months, insiders sold 181,950 shares of company stock worth $13,237,385. 1.02% of the stock is currently owned by insiders.
TRADEMARK VIOLATION WARNING: This report was posted by Watch List News and is the property of of Watch List News. If you are reading this report on another site, it was copied illegally and republished in violation of United States & international copyright and trademark law. The original version of this report can be viewed at https://www.watchlistnews.com/wilkins-investment-counsel-inc-has-4-96-million-position-in-colgate-palmolive-cl/1805420.html.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.